Expert perspectives on the phase II clinical trial assessing IRV triplet therapy in young patients with previously untreated mantle cell lymphoma to help minimize chemotherapy exposure.
Preetesh Jain, MD, PhD
Advertisement
Articles by Preetesh Jain, MD, PhD
Preetesh Jain, MD, PhD, discusses the efficacy of ibrutinib plus rituximab in mantle cell lymphoma.
Preetesh Jain, MD, PhD, discusses the rationale to evaluate ibrutinib in combination with rituximab in mantle cell lymphoma.
Preetesh Jain, MD, PhD, discusses research efforts examining resistance patterns with venetoclax in mantle cell lymphoma.
Preetesh Jain, MD, PhD, discusses the activity of venetoclax (Venclexta) in mantle cell lymphoma (MCL).
Preetesh Jain, MD, PhD, discusses the next steps for a study examining the efficacy of venetoclax in high risk relapsed mantle cell lymphoma.
Preetesh Jain, MD, PhD, discusses response and resistance to venetoclax (Venclexta) in relapsed/refractory mantle cell lymphoma (MCL).
Advertisement
Latest Updated Articles
Dr. Jain on the Activity of Venetoclax in MCLPublished: June 15th 2020 | Updated:
Dr. Jain on the Rationale to Evaluate Ibrutinib/Rituximab in MCLPublished: December 7th 2020 | Updated:
Rapid Readouts: Ibrutinib Plus Rituximab and Venetoclax Followed by Risk-Stratified Chemoimmunotherapy in Young Patients With Previously Untreated MCLPublished: December 23rd 2021 | Updated:
Dr. Jain on Response and Resistance to Venetoclax in Relapsed/Refractory MCLPublished: May 20th 2020 | Updated:
Dr. Jain on Next Steps for Venetoclax in Relapsed MCLPublished: May 22nd 2020 | Updated:
Dr. Jain on Future Research Efforts Examining Venetoclax Resistance Patterns in MCLPublished: June 24th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5